US Patent Issued to Emory University, The UAB Research Foundation, Children's Healthcare of Atlanta on Feb. 4 for "Drug resistant immunotherapy for treatment of a cancer" (Georgia, South Carolina, Alabama Inventors)

ALEXANDRIA, Va., Feb. 5 -- United States Patent no. 12,213,962, issued on Feb. 4, was assigned to Emory University (Atlanta), The UAB Research Foundation (Birmingham, Ala.) and Children's Healthcare of Atlanta Inc. (Atlanta).

"Drug resistant immunotherapy for treatment of a cancer" was invented by Harold Trent Spencer (Marietta, Ga.), Anindya Dasgupta (Anderson, S.C.) and Lawrence S. Lamb (Birmingham, Ala.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure is generally related to methods for combining chemotherapy and immunotherapy for the treatment of a cancer. The methods also relate to generating a drug-resistant cytotoxic immune cell line and uses thereof in conjunction with cytotoxic ...